$DUKR
Stock $dukr

$dukr Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023022590 Filed on March 24, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue		$0.00
YoY Change
Cost Of Revenue			$1.070M
YoY Change
Gross Profit			-$1.070M
YoY Change			-314.0%
Gross Profit Margin
Selling, General & Admin		$223.0K	$1.106M
YoY Change		106.48%	7.8%
% of Gross Profit
Research & Development		$0.00	$20.00K
YoY Change		-100.0%	42.86%
% of Gross Profit
Depreciation & Amortization	$2.000K	$0.00	$2.000K
YoY Change		-100.0%	-33.33%
% of Gross Profit
Operating Expenses	$0.00	$223.0K	$1.126M
YoY Change	-100.0%	108.41%	19.53%
Operating Profit	-$202.0K		-$1.124M
YoY Change	-40.06%		154.3%
Interest Expense		$16.00K	$23.00K
YoY Change		-90.75%	-105.16%
% of Operating Profit
Other Income/Expense, Net			$15.00K
YoY Change			87.5%
Pretax Income		-$207.0K	-$1.101M
YoY Change		-413.64%	23.99%
Income Tax
% Of Pretax Income
Net Earnings	-$179.0K	-$207.0K	-$1.101M
YoY Change	-51.49%	-413.64%	23.99%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00		-$0.06
Diluted Earnings Per Share	$0.00	$0.00	-$0.02
COMMON SHARES
Basic Shares Outstanding	54.22M shares	54.22M shares	54.32M shares
Diluted Shares Outstanding	54.49M shares		54.14M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.621M	$2.849M	$2.849M
YoY Change	-23.25%	-19.97%	-20.04%
Cash & Equivalents	$2.621M	$2.849M	$2.849M
Short-Term Investments
Other Short-Term Assets	$167.0K	$86.00K	$86.00K
YoY Change	496.43%	115.0%	132.43%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$2.788M	$2.935M	$2.935M
YoY Change	-19.02%	-18.47%	-18.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$56.00K	$42.00K	$42.00K
YoY Change	166.67%	366.67%	366.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$152.0K	$15.00K	$15.00K
YoY Change
Total Long-Term Assets	$208.0K	$57.00K	$57.00K
YoY Change	890.48%	533.33%	533.33%
TOTAL ASSETS
Total Short-Term Assets	$2.788M	$2.935M	$2.935M
Total Long-Term Assets	$208.0K	$57.00K	$57.00K
Total Assets	$2.996M	$2.992M	$2.992M
YoY Change	-13.51%	-17.1%	-17.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$87.00K	$85.00K	$85.00K
YoY Change	14.47%	13.33%	13.33%
Accrued Expenses	$236.0K	$176.0K	$176.0K
YoY Change	33.33%	29.41%	29.41%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$323.0K	$261.0K	$261.0K
YoY Change	27.67%	23.7%	23.7%
LONG-TERM LIABILITIES
Long-Term Debt	$307.0K	$305.0K	$305.0K
YoY Change	2.68%	2.69%	2.69%
Other Long-Term Liabilities	$80.00K
YoY Change
Total Long-Term Liabilities	$387.0K	$305.0K	$305.0K
YoY Change	29.43%	2.69%	2.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$323.0K	$261.0K	$261.0K
Total Long-Term Liabilities	$387.0K	$305.0K	$305.0K
Total Liabilities	$710.0K	$566.0K	$566.0K
YoY Change	28.62%	11.42%	11.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.195M	-$9.016M
YoY Change		49.79%
Common Stock	$5.000K	$5.000K
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.286M	$2.426M	$2.426M
YoY Change
Total Liabilities & Shareholders Equity	$2.996M	$2.992M	$2.992M
YoY Change	-13.51%	-17.1%	-17.1%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$179.0K	-$207.0K	-$1.101M
YoY Change	-51.49%	-413.64%	23.99%
Depreciation, Depletion And Amortization	$2.000K	$0.00	$2.000K
YoY Change		-100.0%	-33.33%
Cash From Operating Activities	-$209.0K	-$152.0K	-$672.0K
YoY Change	57.14%	-10.59%	187.18%
INVESTING ACTIVITIES
Capital Expenditures	$16.00K	$20.00K	$35.00K
YoY Change	-233.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$16.00K	-$5.000K	-$35.00K
YoY Change	33.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-$209.0K	-152.0K	-$672.0K
Cash From Investing Activities	-$16.00K	-5.000K	-$35.00K
Cash From Financing Activities		0.000
Net Change In Cash	-$228.0K	-157.0K	-$711.0K
YoY Change		-7.65%	-120.58%
FREE CASH FLOW
Cash From Operating Activities	-$209.0K	-$152.0K	-$672.0K
Capital Expenditures	$16.00K	$20.00K	$35.00K
Free Cash Flow	-$225.0K	-$172.0K	-$707.0K
YoY Change	85.95%		202.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-55504
CY2022	dei	Entity Registrant Name EntityRegistrantName	UAS Drone Corp.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3052410
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	10 HaRimon Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Mevo Carmel Science and Industrial Park
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Israel
CY2022	dei	Entity Address Country EntityAddressCountry	IL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	2069203
CY2022	dei	Security12g Title Security12gTitle	Common Stock, $0.0001 par value
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	4419939	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54218813	shares
CY2022	dei	Auditor Firm AuditorFirmId	650100001
CY2022	dei	Auditor Name AuditorName	Halperin Ilanit
CY2022	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2022Q4	us-gaap	Cash Cash	2849000	usd
CY2021Q4	us-gaap	Cash Cash	3560000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	86000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	2935000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3600000	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Net Noncurrent DeferredCostsLeasingNetNoncurrent	15000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9000	usd
CY2022Q4	us-gaap	Assets Assets	2992000	usd
CY2021Q4	us-gaap	Assets Assets	3609000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	85000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	75000	usd
CY2022Q4	usdr	Other Accounts Liabilities Current OtherAccountsLiabilitiesCurrent	176000	usd
CY2021Q4	usdr	Other Accounts Liabilities Current OtherAccountsLiabilitiesCurrent	136000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	261000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	211000	usd
CY2022Q4	usdr	Stockholders Loans Noncurrent StockholdersLoansNoncurrent	305000	usd
CY2021Q4	usdr	Stockholders Loans Noncurrent StockholdersLoansNoncurrent	297000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	566000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	508000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54218813	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54218813	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54018813	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54018813	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11437000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9115000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9016000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6019000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2426000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3101000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2992000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3609000	usd
CY2021	us-gaap	Revenues Revenues	500000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1104000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1026000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	98000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1124000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-442000	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	19000	usd
CY2021	us-gaap	Financing Interest Expense FinancingInterestExpense	448000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	42000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1101000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-888000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54318060	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49212028	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1849000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	806000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3930000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	686000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	416000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-888000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3101000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	31000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	395000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1101000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2426000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1101000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-888000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	395000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	416000	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	31000	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	8000	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	9000	usd
CY2021	usdr	Expenses With Respect To Change In Fair Value Of Option Granted In Equity Financing ExpensesWithRespectToChangeInFairValueOfOptionGrantedInEquityFinancing	391000	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	15000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	42000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	21000	usd
CY2022	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	10000	usd
CY2021	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-34000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	40000	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-110000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-672000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-234000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4649000	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	954000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3689000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-4000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-711000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3455000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3560000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2849000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3560000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	59000	usd
CY2021	usdr	Issuance Of Shares In Exchange For Convertible Loans IssuanceOfSharesInExchangeForConvertibleLoans	806000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	719000	usd
CY2020Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.0001
CY2018Q4	usdr	Carry Forward Losses For Tax Description CarryForwardLossesForTaxDescription	As of December 31, 2022, the Company and subsidiaries have carry forward losses for tax purposes of approximately $1,521 and $2,486, respectively, which can be offset against future taxable income, if any.
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><b>B.</b></td><td style="text-align: left"><b>Use of estimates in the preparation of financial statements </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.6pt; text-align: left"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to share based compensation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"> </p>
CY2022	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><b>I.</b></td><td style="text-align: left"><b>Revenue recognition </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The Group recognizes revenue when it satisfies performance obligations under the terms of its contracts, and control of its products is transferred to its customers in an amount that reflects the consideration the Company expects to receive from its customers in exchange for those products. This process involves identifying the customer contract, determining the performance obligations in the contract, determining the transaction price, allocating the transaction price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it (a) provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and (b) is separately identified in the contract. The Company considers a performance obligation satisfied once it has transferred control of a good or product to a customer, meaning the customer has the ability to direct the use and obtain the benefit of the product.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt"> </p>
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	95000	usd
CY2022	usdr	Other Accrued Expenses OtherAccruedExpenses	16000	usd
CY2021	usdr	Other Accrued Expenses OtherAccruedExpenses	41000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><b>M.</b></td><td style="text-align: left"><b>Concentrations of credit risk</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents as well as certain other current assets that do not amount to a significant amount. Cash and cash equivalents, which are primarily held in Dollars and New Israeli Shekels, are deposited with major banks in Israel and the United States. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"> </p>
CY2022	usdr	Total Accrued Expenses TotalAccruedExpenses	176000	usd
CY2021	usdr	Total Accrued Expenses TotalAccruedExpenses	136000	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	78000	usd
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	23000	usd
CY2022Q4	us-gaap	Government Contract Receivable GovernmentContractReceivable	8000	usd
CY2021Q4	us-gaap	Government Contract Receivable GovernmentContractReceivable	14000	usd
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	86000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	40000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	72000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	30000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	2000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	3000	usd
CY2022	usdr	Purchased Amount PurchasedAmount	35000	usd
CY2021	usdr	Purchased Amount PurchasedAmount	0	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	160000	usd
CY2022Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.03	pure
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	15000000	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3000000	usd
CY2021Q2	usdr	Purchase Agreement Description PurchaseAgreementDescription	the Company entered into Securities Purchase Agreements (the “Securities Purchase Agreements”) with eight (8) non-U.S. investors, pursuant to which the Company, in a private placement offering (the “Offering”), agreed to issue and sell to the investors an aggregate of: (i) 12,500,000 shares of the Company’s Common Stock, at a price of $0.40 per share; and (ii) warrants (the “Warrants”) to purchase 12,500,000 Company’s Common Stock. The Warrants are exercisable immediately and for a term of 18 months and have an exercise price of $0.40 per share. The aggregate gross proceeds from the Offering were approximately $5,000.
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1070000	usd
CY2021Q2	us-gaap	Other Commitments Description OtherCommitmentsDescription	Pursuant to the service agreement, the Company agreed to pay the service provider (1) 6% of the investment amounts received which amounted to $351 and (2) options to receive a number of units (each unit for a price of $0.40 includes one share and one warrant with an exercise price of $0.40 per share) equal to 6% of the investment amount received, divided by $0.40.In the event that the investors that participated in the Offering exercise their Warrants, the service provider shall be entitled to receive an additional payment of (1) 6% of the investment amounts received (2) 6% of the warrants exercised amounts received and (3) options to receive a number of units equal to 6% of the warrants exercised amounts received, divided by $0.40.
CY2022Q4	usdr	Offering Cost OfferingCost	686000	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.8032	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0011	pure
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y6M29D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	400
CY2021Q2	us-gaap	Share Price SharePrice	320
CY2021Q2	usdr	Fair Value FairValue	686000	usd
CY2022Q4	us-gaap	Fair Value Concentration Of Risk Cash And Cash Equivalents FairValueConcentrationOfRiskCashAndCashEquivalents	16000	usd
CY2022Q1	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	300000000	shares
CY2022Q1	usdr	Number Of Tranches NumberOfTranches	three
CY2022Q1	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	100000	shares
CY2022Q3	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	100000	shares
CY2022	usdr	Share Based Compensation Expense ShareBasedCompensationExpense	31000	usd
CY2022	usdr	Recoup Of Investment Amount RecoupOfInvestmentAmount	0.50	pure
CY2022Q4	us-gaap	Investments Investments	6000000	usd
CY2022	usdr	Offsetting Of Royalty Payment OffsettingOfRoyaltyPayment	0.50	pure
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y
CY2022Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P2Y
CY2022	us-gaap	Lease Cost LeaseCost	5200000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	995000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.7
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2445443	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.82
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1013631	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.67
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2426812	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.81
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2426812	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.81
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1387092	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.95
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	54000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice	0.12
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2426812	shares
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y3M10D
CY2022	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	1387092
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2426812	shares
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y3M10D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	137	shares
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	395000	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	416000	usd
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.05	pure
CY2022Q4	us-gaap	Other Commitment OtherCommitment	15000	usd
CY2022Q3	usdr	Government And Public Owned Percentage GovernmentAndPublicOwnedPercentage	0.99	pure
CY2022	usdr	Percentage Of Statutory Rate PercentageOfStatutoryRate	0.21	pure
CY2018Q4	usdr	Percentage Of Corporate Tax Rate PercentageOfCorporateTaxRate	0.23	pure
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.9347	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0007	pure
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	891000	usd
CY2022	usdr	Riskfree Rate RiskfreeRate	0	usd
CY2022	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	598000	usd
CY2021	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	521000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	426000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	416000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	47000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	50000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1000	usd
CY2022	us-gaap	Cost Maintenance CostMaintenance	12000	usd
CY2021	us-gaap	Cost Maintenance CostMaintenance	26000	usd
CY2022	us-gaap	Other General Expense OtherGeneralExpense	2000	usd
CY2021	us-gaap	Other General Expense OtherGeneralExpense	1000	usd
CY2022	us-gaap	Depreciation Depreciation	2000	usd
CY2021	us-gaap	Depreciation Depreciation	3000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	15000	usd
CY2021	us-gaap	Other Expenses OtherExpenses	8000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1104000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1026000	usd
CY2022	usdr	Agreement Term AgreementTerm	P15Y
CY2022	usdr	Cummulative Revenue Form Sale CummulativeRevenueFormSale	50000000	usd
CY2022	usdr	Pretax Loss PretaxLoss	-1101000	usd
CY2021	usdr	Pretax Loss PretaxLoss	-888000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	231000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	186000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-83000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-87000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	5000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-82000	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	10000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-163000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-17000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	875000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	704000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	875000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	704000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	171	usd
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	54318060000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	49212028000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17701812000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17926812000	shares
CY2022	usdr	Directors Compensation DirectorsCompensation	529000	usd
CY2021	usdr	Directors Compensation DirectorsCompensation	502000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	144000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	162000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	8000	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	9000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	35000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	33000	usd
CY2022Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	305000	usd
CY2021Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	276000	usd
CY2021Q1	usdr	Description Of Board Of Directors DescriptionOfBoardOfDirectors	the Board of Directors appointed Yossi Balucka to serve as its Chief Executive Officer. Mr. Balucka is entitled to a monthly fee of NIS30,000 (approximately $9,650), reimbursement of expenses and discretionary performance bonus. In conjunction with the appointment of Mr. Balucka, the Company issued to Mr. Balucka options to purchase 450,000 shares of the Company’s commons stock at an exercise price of $0.0001 per share, subject to and in accordance with the terms and conditions of an Option Plan.
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2022	usdr	Total Value Of Share Based Compensation TotalValueOfShareBasedCompensation	61000	usd
CY2021Q3	usdr	Issuance Options To Purchase Shares IssuanceOptionsToPurchaseShares	490000	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.38
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2021Q4	us-gaap	Deferred Costs Leasing Net Noncurrent DeferredCostsLeasingNetNoncurrent		usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022	usdr	Expenses With Respect To Change In Fair Value Of Option Granted In Equity Financing ExpensesWithRespectToChangeInFairValueOfOptionGrantedInEquityFinancing		usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	usdr	Issuance Of Shares In Exchange For Convertible Loans IssuanceOfSharesInExchangeForConvertibleLoans		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures		usd
CY2021	usdr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriod		shares
CY2022	usdr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes		usd
CY2022	usdr	Total Federal Tax Rate TotalFederalTaxRate		usd
CY2021	usdr	Total Federal Tax Rate TotalFederalTaxRate		usd
CY2022	usdr	Total Composition Of Deferred Tax Assets TotalCompositionOfDeferredTaxAssets		usd
CY2021	usdr	Total Composition Of Deferred Tax Assets TotalCompositionOfDeferredTaxAssets		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	City Area Code CityAreaCode	+972-4-
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001638911
CY2022	dei	Local Phone Number LocalPhoneNumber	8124101

Files In Submission

Name	View Source	Status
0001213900-23-022590-index-headers.html	Edgar Link	pending
0001213900-23-022590-index.html	Edgar Link	pending
0001213900-23-022590.txt	Edgar Link	pending
0001213900-23-022590-xbrl.zip	Edgar Link	pending
f10k2022ex23-1_uasdrone.htm	Edgar Link	pending
f10k2022ex23-2_uasdrone.htm	Edgar Link	pending
f10k2022ex31-1_uasdrone.htm	Edgar Link	pending
f10k2022ex31-2_uasdrone.htm	Edgar Link	pending
f10k2022ex32-1_uasdrone.htm	Edgar Link	pending
f10k2022ex32-2_uasdrone.htm	Edgar Link	pending
f10k2022_uasdronecorp.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10k2022_uasdronecorp_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
usdr-20221231.xsd	Edgar Link	pending
usdr-20221231_pre.xml	Edgar Link	unprocessable
usdr-20221231_cal.xml	Edgar Link	unprocessable
usdr-20221231_def.xml	Edgar Link	unprocessable
usdr-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DUKR
Stock $dukr

2023 Q1 Form 10-K Financial Statement

#000121390023022590 Filed on March 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DUKR Stock $dukr

2023 Q1 Form 10-K Financial Statement

#000121390023022590 Filed on March 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DUKR
Stock $dukr